These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3721580)

  • 21. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
    Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenic Potency of a Chimeric Protein Comprising InvH and IpaD against Salmonella and Shigella spp.
    Emami Mahmoudabadi FS; Vakili A; Nazarian S; Amani J; Mousavi Gargari SL
    Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):484-493. PubMed ID: 34418902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.
    Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M
    J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congo red-mediated regulation of levels of Shigella flexneri 2a membrane proteins.
    Sankaran K; Ramachandran V; Subrahmanyam YV; Rajarathnam S; Elango S; Roy RK
    Infect Immun; 1989 Aug; 57(8):2364-71. PubMed ID: 2663721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shigella lipopolysaccharide antibodies in pediatric populations.
    Passwell JH; Freier S; Shor R; Farzam N; Block C; Lison M; Shiff E; Ashkenazi S
    Pediatr Infect Dis J; 1995 Oct; 14(10):859-65. PubMed ID: 8584312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.
    Akbari MR; Saadati M; Honari H; Ghorbani HM
    Iran J Immunol; 2019 Sep; 16(3):212-224. PubMed ID: 31552830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection.
    Van De Verg LL; Bendiuk NO; Kotloff K; Marsh MM; Ruckert JL; Puryear JL; Taylor DN; Hartman AB
    Vaccine; 1996 Aug; 14(11):1062-8. PubMed ID: 8879103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations.
    Van de Verg LL; Herrington DA; Boslego J; Lindberg AA; Levine MM
    J Infect Dis; 1992 Jul; 166(1):158-61. PubMed ID: 1607690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.
    Chitradevi ST; Kaur G; Uppalapati S; Yadav A; Singh D; Bansal A
    Cell Mol Immunol; 2015 Nov; 12(6):757-67. PubMed ID: 25640657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.
    Formal SB; Hale TL; Kapfer C; Cogan JP; Snoy PJ; Chung R; Wingfield ME; Elisberg BL; Baron LS
    Infect Immun; 1984 Nov; 46(2):465-9. PubMed ID: 6389344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD).
    Turbyfill KR; Mertz JA; Mallett CP; Oaks EV
    Infect Immun; 1998 May; 66(5):1999-2006. PubMed ID: 9573082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of virulent Shigella and enteroinvasive Escherichia coli by induction of the 43 kDa invasion plasmid antigen, ipaC.
    Shamlal R; Rajarathnam S; Sankaran K; Ramachandran V; Subrahmanyam YV; Nair GB; Macaden R; Roy RK
    FEMS Immunol Med Microbiol; 1997 Feb; 17(2):73-8. PubMed ID: 9061352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput
    Nahm MH; Yu J; Weerts HP; Wenzel H; Tamilselvi CS; Chandrasekaran L; Pasetti MF; Mani S; Kaminski RW
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898979
    [No Abstract]   [Full Text] [Related]  

  • 35. Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies.
    Mills JA; Buysse JM; Oaks EV
    Infect Immun; 1988 Nov; 56(11):2933-41. PubMed ID: 2459066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.
    van de Verg LL; Mallett CP; Collins HH; Larsen T; Hammack C; Hale TL
    Infect Immun; 1995 May; 63(5):1947-54. PubMed ID: 7729907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes.
    Kärnell A; Sweiha H; Lindberg AA
    Vaccine; 1992; 10(3):167-74. PubMed ID: 1557932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections.
    Cohen D; Block C; Green MS; Lowell G; Ofek I
    J Clin Microbiol; 1989 Jan; 27(1):162-7. PubMed ID: 2463995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two novel virulence loci, mxiA and mxiB, in Shigella flexneri 2a facilitate excretion of invasion plasmid antigens.
    Andrews GP; Hromockyj AE; Coker C; Maurelli AT
    Infect Immun; 1991 Jun; 59(6):1997-2005. PubMed ID: 2037361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.